Charles River Laboratories Announces David J. Elliott to Join Charles River as Corporate Controller

At Charles River, Mr. Elliott's key responsibilities will includeglobal accounting, financial reporting and compliance with Sarbanes -Oxley. Mr. Elliott will report directly to Thomas Ackerman, SeniorVice President and Chief Financial Officer.

James C. Foster, Chairman, President and Chief Executive Officerof Charles River stated, "I'm pleased to welcome Dave to CharlesRiver. He brings to the Company extensive experience in domestic andinternational accounting and controls. He has experience inacquisitions and systems implementations and will provide strongleadership as we continue to grow."

About Charles River Laboratories

Charles River Laboratories, based in Wilmington, Massachusetts, isa global provider of solutions that advance the drug discovery anddevelopment process. Our leading-edge products and services aredesigned to enable our clients to bring drugs to market faster andmore efficiently. Backed by our rigorous, best-in-class procedures andour proven data collection, analysis and reporting capabilities, ourproducts and services are organized into three categories spanningevery step of the drug development pipeline: Research Models andServices, Preclinical Services, and Clinical Services. Charles River'scustomer base includes all of the major pharmaceutical companies andmany biotechnology companies, government agencies and leadinghospitals and academic institutions. Charles River's 8,000 employeesserve clients in more than 50 countries. For more information onCharles River, visit our website at www.criver.com.